Baharan Fekry

Baharan Fekry

Auto-generated profile, based on publicly available information

Baharan Fekry

Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, TX, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2018 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
ARAleix Ribas-Latre
Aleix Ribas-Latre
BFBaharan Fekry
Baharan Fekry
CKChristopher Kwok
Christopher Kwok
CBCorrine Baumgartner
Corrine Baumgartner
SSSamay Shivshankar
Samay Shivshankar
KEKristin L. eckel-mahan
Kristin L. eckel-mahan
Nutrient challenge in the form of a high fat (HF) diet causes a reversible reprogramming of the hepatic circadian clock. This depends in part on changes in the recruitment of the circadian transcription factor BMAL1 to genome targets, though the causes and extent of disruption to hepatic and extra-hepatic BMAL1 are unknown. The objective of the study was to determine whether HF diet-induced alterations in BMAL1 function occur across insulin-resistant tissues and whether this could be reversed by restoring whole body insulin sensitivity. BMAL1 subcellular localization and target recruitment was analyzed in several metabolically active peripheral tissues, including liver, muscle, and adipose tissue under conditions of diet-induced obesity. Animals made obese with HF diet were subsequently treated with rosiglitazone to determine whether resensitizing insulin-resistant tissues to insulin restored hepatic and extra-hepatic BMAL1 function. These data reveal that both hepatic and extra-hepatic BMAL1 activity are altered under conditions of obesity and insulin resistance. Restoring whole body insulin sensitivity by treatment with the antidiabetic drug rosiglitazone is sufficient to restore changes in HF diet-induced BMAL1 recruitment and activity in several tissues. This study reveals that a key mechanism by which HF diet interferes with clock function in peripheral tissues is via the development of insulin resistance.

18 June 2026 in Journal of Psychopharmacology
Verified
Journal Article
Open access
LULierni Ugartemendia Ugalde
Lierni Ugartemendia Ugalde
BFBaharan Fekry
Baharan Fekry
RSRobert Suchting
Robert Suchting
RSRafael Bravo Santos
Rafael Bravo Santos
CIChioma A. Ikedionwu
Chioma A. Ikedionwu
LGLaura Goetzl
Laura Goetzl
Background: Cannabis is widely used during pregnancy, increasing with cannabis legalization, and has been associated with altered neurodevelopment, yet the precise molecular mechanisms remain poorly understood. Aims: To assess whether utilizing fetal central nervous system-derived extracellular vesicles (fCNSEVs) isolated from maternal blood reflects cannabis-associated changes in the fetal brain. Methods: In a matched case-control study, maternal plasma (to isolate fCNSEVs) and paired fetal cortical tissue (9–18 weeks’ gestation) from pregnancies exposed or unexposed to cannabis were collected. We quantified protein (CB1R, D2R) and miRNA expression (using µ-paraflo TM microarray). Selected miRNAs were validated by qPCR. Bayesian Generalized Linear Models were used to assess exposure-group by sex effects. Results: Maternal cannabis use was associated with altered CB1R and D2R levels in the brain with opposite directional changes in fCNSEVs. 21 miRNAs were differentially expressed: 14 downregulated and 6 upregulated, following a sex-dependent pattern (males>>females), while miR-216a-5p follows the opposite pattern (females>>males). We confirmed concordant miRNA changes in fetal brain and fCNSEVs. Many of the identified molecules are associated with pathways linked to adverse neurodevelopmental outcomes. Conclusions: Our data suggest that fCNSEV-based assays may provide the ability to monitor fetal brain effects of maternal cannabis in ongoing pregnancies in clinical cohorts. A critical next step is to determine if alterations in fCNSEV protein and miRNA markers predict changes in fetal brain connectivity and neurodevelopment measures of executive function.

12 October 2023
Verified
Book Chapter
Closed access
BFBaharan Fekry
Baharan Fekry
KEKristin L. eckel-mahan
Kristin L. eckel-mahan
Biological Implications of Circadian Disruption - October 2023

15 June 2022 in Cancer Research
Verified
Journal Article
Open access
MRMegan Rodriguez
Megan Rodriguez
MFMary Figueroa
Mary Figueroa
BMBrianna Murphy
Brianna Murphy
TCTiewei Cheng
Tiewei Cheng
BFBaharan Fekry
Baharan Fekry
JCJoya Chandra
Joya Chandra
Acute myeloid leukemia (AML) with a mutation in the fms-like tyrosine kinase receptor 3 gene (FLT3) confers poor survival for pediatric patients, indicating a significant need to improve treatment efficacy. A significant percentage of pediatric patients consume diets high in fat and sugar content. These macronutrients modulate oxidative stress yet their impact on AML treatment is unexplored. Studies have implicated a role for BMAL1 rhythmicity, a circadian clock protein, in leukemogenesis. However, BMAL1 has not been studied in FLT3 mutant AML. Given that both nutrition and circadian rhythmicity can be modulated by behavior, we hypothesized that modulating redox and BMAL1 status through diet composition and timing would enhance treatment efficacy in an orthotopic mouse model. In all in vivo experiments, mice were injected via tail vein with 100,000 MOLM13 luciferase labelled cells, a FLT3 AML human cell line. After engraftment was confirmed 3 days later, mice were put on diet modification regimens. In three subsequent experiments, distinct diet interventions were delivered: low fat (30%)/low sucrose (10%), low sucrose alone (10%), or an isocaloric time feeding regimen (TRF) restricted to mice’s active phase (7 PM to 7 AM). Standard chow, high sucrose diet (45%) and ad libitum feeding were controls, respectively. In each experiment, doxorubicin (2 mg/kg) or PBS was injected twice weekly via tail vein. Tumor burden was monitored via bioluminescent imaging. Reactive oxygen species (ROS) levels were assessed with flow cytometry, and changes in circadian, redox, and apoptotic protein expression were measured by western blot and mass cytometry. On day 17, in the presence of doxorubicin, mice on a low fat/low sucrose diet showed significantly lower tumor burden compared to control. Doxorubicin induced oxidative stress was reduced in the mice fed the modified diet as demonstrated by a decrease in ROS levels in peripheral blood mononuclear cells. Even in the absence of doxorubicin treatment, the modified diet group showed significantly lower tumor burden on day 17. For mice on a low sucrose diet, changes in redox and circadian protein expression were observed on day 17. Of note, total BMAL1 protein showed a two-fold increase in spleen from the low sucrose group. In the timed feeding experiments, we observed TRF mice had significantly reduced leukemic burden on day 14. Importantly, doxorubicin efficacy was not compromised by TRF. In addition, a significant increase in total BMAL1 protein expression was observed in liver from these TRF mice on day 14. These results point to a novel finding: diet composition and timing slows progression of FLT3 AML growth in vivo and are accompanied by BMAL1 modulation. In future studies, we aim to further define the role of circadian rhythmicity and diet composition in AML progression and identify methods to complement treatment to positively impact survival outcomes for patients diagnosed with AML. Citation Format: Megan Rodriguez, Mary Figueroa, Brianna Murphy, Tiewei Cheng, Baharan Fekry, Kendra Allton, Michelle Barton, Marina Konopleva, Kristin Mahan, Joya Chandra. Effects of diet composition and timing on treatment for FLT3 positive acute myeloid leukemia [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 726.